Pharmaprogress s.r.o.

Active
IČO 46883452limited liability company (s.r.o.)Founded 2012Žilina

Key figures

739 961 €-2,6%
Revenue 2025
-6,4%
Average annual change 2020–2025
0500 k1 m1,5 m202020212022202320242025

Key figures

2025

Dividends

calculated
2025

Distributed as dividends 18 057 €.

Low confidence: the amount exceeds the retained earnings from which dividends can be distributed — probably a merger, an opening balance adjustment or an error in the financial statements.

History
2025 ~18 057 €
20240 €
20230 €
20220 €
20210 €

Summary: Pharmaprogress s.r.o.

What kind of company is it?

Pharmaprogress s.r.o. (IČO 46883452) is a limited liability company (s.r.o.). The company was incorporated in 2012 and has existed for 13 years. Registered office according to the register: Žilina. Main activity according to the Statistical Office: ostatné vzdelávanie i. n. (SK NACE 8559). Size category by number of employees: 3–4 employees.

Who runs the company and who owns it?

The statutory body has 2 members. According to the register, the company has 2 shareholders. The registered capital is 5 000 €.

How is the company doing financially?

Revenue for 2025 was 739 961 €, down 2,6 % on the previous year (759 339 €). From 2020 to 2025, revenue fell by an average of 6,4 % per year. This is the lowest revenue in the reported years (2020–2025). 2025 ended with a loss of 55 757 €. The company was profitable in 1 of the 6 reported years. Personnel costs for 2025 were 132 556 €.

What should you look out for?

Equity was negative at the end of 2025 (-193 253 €).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 19. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)740 550839 142915 725759 339739 961
Profit for the reporting year-3 16511 499-58 803-49 778-55 757
Retained earnings of previous periods-424 192-427 357-415 858-474 661-542 496
Total assets335 077288 603262 294224 919217 582
Total liabilities757 434699 461731 955344 358410 835
Total equity-422 357-410 858-469 661-119 439-193 253
Calculated dividends000018 057

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph
50 % · director50 % · directorPharmaprogress s.r.o.Pharmaprogress s.r.o.MHMiroslav HruškaMiroslav HruškaMSMiroslav SandanusMiroslav Sandanus
PersonCompanyOwnership (thickness = share)Role in a bodyZoom: Ctrl/⌘ + wheel

The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.

Documents in the Register of Financial Statements12

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same industry (SK NACE 8559)
Pharmaprogress s.r.o. (IČO 46883452) – revenue 740K € | icoprofil.sk